首页 > 用药指导 > 文章详情

Baricitinib(艾乐明)巴瑞替尼2023价格

发布时间:2024-02-21 14:12:28 阅读:1328 来源:问药网
分享至

分享到微信朋友圈

×

打开微信,点击底部的“发现”,

使用“扫一扫”即可将网页分享至朋友圈。

巴瑞替尼

巴瑞替尼 生产厂家:印度纳科Natco制药有限公司 功能主治:JAK1/2抑制剂,用于多种炎症性疾病和自身免疫性疾病 用法用量:  1、类风湿性关节炎  OLUMIANT的推荐剂量为每日1次口服2mg,餐前餐后都可。  OLUMIANT可以单独使用,也可以与甲氨蝶呤或其他非生物dmard联合使用。  2、COVID-19(新冠病毒)  成人OLUMIANT的推荐剂量为每日一次口服4mg,餐前餐后都可,持续14天或直到出院,以先发生者为准。  3、斑秃  OLUMIANT的推荐剂量是2mg,每天一次口服,餐前餐后都可。  如果对治疗的反应不充分,增加到每天一次4mg。  对于几乎完全或完全的头皮脱发,睫毛或眉毛有或没有大量脱发的患者,考虑每天一次4mg治疗,伴餐前餐后都可。  一旦患者对4mg的治疗产生了充分的反应,将剂量减少到2mg,每天一次。  对于无法吞下整片药片的患者,可以考虑另一种给药方式:  1、口服分散  2、胃造口管(G管)  3、鼻胃管(NG管)或口胃管(OG管)
查看详情

Baricitinib(艾乐明)巴瑞替尼2023价格,Baricitinib(Baricitinib)的版本有:1、孟加拉耀品国际版本;2、孟加拉伊思达版本;3、印度natco版本;4、孟加拉方圆版本;5、孟加拉碧康制药版本。代购价格是380元左右,不同版本价格不同,以实际为准。请选择正规海外代购渠道,以保证产品质量。

Baricitinib (brand name Olumiant) is a medication that has gained significant attention in recent years due to its multiple applications in the field of medicine. Originally developed for the treatment of rheumatoid arthritis, baricitinib has also shown promise in the management of COVID-19 and alopecia areata (spot baldness). In this article, we will explore the price of baricitinib in 2023, its significance in various medical conditions, and its impact on healthcare.

1. The Accurate Price of Baricitinib in 2023

As of 2023, the price of baricitinib may vary depending on several factors such as the country, dosage strength, and the specific brand under which it is marketed. However, to obtain the most accurate and up-to-date information on the price, it is recommended to consult with a healthcare professional or local pharmacy. They will be able to provide the precise cost based on your location and prescription requirements.

2. Baricitinib in the Treatment of Rheumatoid Arthritis

Baricitinib is primarily indicated for the treatment of rheumatoid arthritis, a chronic autoimmune disease characterized by inflamed joints and subsequent pain and stiffness. It works by inhibiting Janus kinases (JAK), which are enzymes involved in the signaling pathways associated with inflammation. The drug helps reduce the symptoms of rheumatoid arthritis and improve patients' overall quality of life. The availability and affordability of baricitinib are crucial for those living with this condition.

3. Baricitinib's Role in COVID-19 Management

During the COVID-19 pandemic, baricitinib has emerged as a potential treatment option for hospitalized patients with severe illness. When used in combination with other medications, such as remdesivir, baricitinib has shown beneficial effects in reducing the need for invasive mechanical ventilation and shortening the recovery time for some individuals. The price of baricitinib becomes particularly significant when considering its potential impact on public health during widespread outbreaks.

4. Baricitinib for Alopecia Areata

Alopecia areata is an autoimmune condition that causes sudden hair loss, often leading to patchy bald spots on the scalp. Baricitinib has demonstrated positive results as a treatment for alopecia areata by modulating immune responses involved in hair follicle destruction. Its potential use in this dermatological condition highlights the importance of accessibility to baricitinib for those affected by alopecia areata, which can significantly impact mental well-being and self-esteem.

Conclusion:

Baricitinib, known as Olumiant, has an important role to play in the treatment of rheumatoid arthritis, COVID-19, and alopecia areata. While the price of baricitinib may vary depending on location and other factors, its accessibility is crucial for individuals who can benefit from its therapeutic effects. Continued research and development, as well as the availability of affordable options, will aid in ensuring that patients have access to this medication when needed, ultimately improving the outcomes and quality of life for those with these medical conditions.